These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11205474)

  • 1. Docetaxel and cisplatin in head and neck cancer.
    Schöffski P; Wanders J; Verweij J; Fumoleau P;
    Ann Oncol; 2000 Dec; 11(12):1617. PubMed ID: 11205474
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck.
    Specht L; Larsen SK; Hansen HS
    Ann Oncol; 2000 Jul; 11(7):845-9. PubMed ID: 10997812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
    Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer.
    Janinis J; Panagos G
    J Clin Oncol; 2000 Mar; 18(6):1393-5. PubMed ID: 10715312
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
    Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
    Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
    Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
    J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
    Gedlicka C; Kornek GV; Schmid K; Scheithauer W
    Ann Oncol; 2003 Feb; 14(2):339-40. PubMed ID: 12562664
    [No Abstract]   [Full Text] [Related]  

  • 8. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
    Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
    Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two patients with distant metastases from head and neck squamous cell carcinomas successfully treated with docetaxel and cisplatin].
    Okami K; Sakai A; Onuki J; Odagiri K; Takahashi M
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):95-9. PubMed ID: 12557711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.
    Baur M; Kienzer HR; Schweiger J; DeSantis M; Gerber E; Pont J; Hudec M; Schratter-Sehn AU; Wicke W; Dittrich C
    Cancer; 2002 Jun; 94(11):2953-8. PubMed ID: 12115384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.
    Schöffski P; Weihkopf T; Ganser A
    Anticancer Res; 1998; 18(6B):4751-6. PubMed ID: 9891552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.
    Saito Y; Kobayashi M; Yamada T; Kasashi K; Honma R; Takeuchi S; Shimizu Y; Kinoshita I; Dosaka-Akita H; Iseki K
    Support Care Cancer; 2017 Feb; 25(2):481-487. PubMed ID: 27699503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN).
    Colevas AD; Norris CM; Tishler RB; Lamb CC; Fried MP; Goguen LA; Gopal HV; Costello R; Read R; Adak S; Posner MR
    Am J Clin Oncol; 2002 Apr; 25(2):153-9. PubMed ID: 11943893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
    J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility study.
    Janinis J; Papadakou M; Xidakis E; Boukis H; Poulis A; Panagos G; Lefantzis D
    Am J Clin Oncol; 2000 Apr; 23(2):128-31. PubMed ID: 10776971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxoids in head and neck cancer: the American approach.
    Forastiere AA
    Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.
    Colevas AD; Norris CM; Tishler RB; Fried MP; Gomolin HI; Amrein P; Nixon A; Lamb C; Costello R; Barton J; Read R; Adak S; Posner MR
    J Clin Oncol; 1999 Nov; 17(11):3503-11. PubMed ID: 10550148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG).
    Caponigro F; Massa E; Manzione L; Rosati G; Biglietto M; De Lucia L; Sguotti C; Sganga P; Avallone A; Comella P; Mantovani G; Comella G
    Ann Oncol; 2001 Feb; 12(2):199-202. PubMed ID: 11300324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.